Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Safety and Efficacy Study in Patients With Gastric Cancer

ClinicalTrials.gov ID: NCT00400179

Public ClinicalTrials.gov record NCT00400179. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Multicenter, Randomized, Phase 3 Study of S-1 in Combination With Cisplatin Against 5-Fu in Combination W/ Cisplatin in Patients W/ Advanced Gastric Cancer Previously Untreated W/ Chemotherapy for Advanced Disease

Study identification

NCT ID
NCT00400179
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Taiho Oncology, Inc.
Industry
Enrollment
1,053 participants

Conditions and interventions

Conditions

Interventions

  • S-1/Cisplatin Drug
  • 5-FU/cisplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2005
Primary completion
Feb 29, 2008
Completion
Mar 31, 2008
Last update posted
Sep 18, 2024

2005 – 2008

United States locations

U.S. sites
32
U.S. states
18
U.S. cities
26
Facility City State ZIP Site status
Clearview Cancer Center Huntsville Alabama 35801
Saint Joseph Medical Center Burbank California 91505
Dr. Ronald Yanagihara Gilroy California 95020
Norris Cancer Center Los Angeles California 90033
Comprehensive Cancer Center Palm Springs California 92262
Saint Francis Memorial Hospital San Francisco California 94109
Premiere Oncology Santa Monica California 90404
Western Hematology/Oncology Lakewood Colorado 80215
Broward Oncology Associates Fort Lauderdale Florida 33308
Alexandar Rosemurgy Tampa Florida 33606
Palm Beach Cancer Institute West Palm Beach Florida 33401
Straub Clinic and Hospital Honolulu Hawaii 96813
Robert H. Lurie Comprehensive Cancer Center Chicago Illinois 60611
University of Chicago Medical Center Chicago Illinois 60637-1470
Oncology and Hematology Metairie Louisiana 70006
St. Lukes Cancer Care Center Duluth Minnesota 55802
Neuroscience Center St Louis Missouri 63110
St. Louis University Cancer Center St Louis Missouri 63110
Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106
AHS Lovelace Medical Group,LLC Albuquerque New Mexico 87102
New Mexico Cancer Center Associates Albuquerque New Mexico 87106
University of New Mexico Albuquerque New Mexico 87106
Hoo Chun, MD Hawthorne New York 10532
Hematology/Oncology Associates of Rockland New City New York 10956
New Bern Cancer Care New Bern North Carolina 28560
Abramson Cancer Center Philadelphia Pennsylvania 19104
Thomas Jefferson University Philadelphia Pennsylvania 19107
Charleston Cancer Center Charleston South Carolina 29406
Associates in Oncology and Hematology Chattanooga Tennessee 37404
Lexington Oncology Associates Chattanooga Tennessee 37404
MD Anderson Cancer Center Houston Texas 77030
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00400179, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2024 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00400179 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →